Investors are likely to keep an eye on the following small-cap stocks listed on the Australian Securities Exchange.

Amplia Therapeutics (ASX:ATX)

Amplia Therapeutics said data from its phase 2a clinical trial showed "promising efficacy and good tolerability." The trial is investigating the use of its focal adhesion kinase inhibitor narmafotinib in combination with standard chemotherapy for advanced pancreatic cancer treatment.

Recharge Minerals (ASX:REC)

Recharge Minerals started the permitting process for exploration drilling at the Carter project in Montana, working with a consulting group to ensure environmental and land use compliance for future drill programs.

Raiden Resources (ASX:RDN)

Raiden Resources began second-phase drilling on the Vuzel project in Bulgaria, aiming to assess the area's potential to host a near-surface gold deposit.

Desert Metals (ASX:DM1)

Desert Metals started an 86-hole, 3,500-meter air core drilling program at the Tengrela South gold permit in the Ivory Coast, aiming to test the weathered oxide layer of northern gold anomalies at the Kakologo and Tiogo prospects.

Scorpion Metals (ASX:SCN)

Scorpion Minerals received binding commitments to raise AU$250,000 via placement of 12.5 million shares at AU$0.02 apiece. Proceeds will be used to expand the drilling of gold targets in the Pharos project and Jungar Flats joint venture in Western Australia, and for general working capital.